Compare OCGN & NECB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OCGN | NECB |
|---|---|---|
| Founded | 2013 | 1934 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 419.8M | 368.0M |
| IPO Year | 2014 | 2021 |
| Metric | OCGN | NECB |
|---|---|---|
| Price | $1.29 | $26.62 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $9.75 | ★ $30.00 |
| AVG Volume (30 Days) | ★ 5.7M | 38.1K |
| Earning Date | 05-05-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 4.12% |
| EPS Growth | ★ 31.58 | N/A |
| EPS | N/A | ★ 0.74 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $4.85 |
| Revenue Next Year | $1,718.38 | $8.45 |
| P/E Ratio | ★ N/A | $36.03 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.93 | $19.27 |
| 52 Week High | $2.73 | $28.94 |
| Indicator | OCGN | NECB |
|---|---|---|
| Relative Strength Index (RSI) | 40.03 | 52.15 |
| Support Level | $1.13 | $22.56 |
| Resistance Level | $1.58 | $28.94 |
| Average True Range (ATR) | 0.07 | 0.73 |
| MACD | -0.02 | -0.09 |
| Stochastic Oscillator | 18.75 | 44.73 |
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
NorthEast Community Bancorp Inc operates as a community-oriented financial institution. It is principally engaged in the business of attracting deposits and investing those funds into mortgage and commercial loans. It conducts activities throughout the Northeastern United States, including New York, Massachusetts, New Jersey, and Connecticut. The company offers a comprehensive line of banking products and services, including mobile banking as well as commercial real estate loans, commercial construction financing, lines of credit, and term loans. It also offers investment advisory and financial planning services.